Data as of Dec 19
| -0.35 / -0.70%|
The 14 analysts offering 12-month price forecasts for Imperva Inc have a median target of 46.00, with a high estimate of 58.00 and a low estimate of 35.00. The median estimate represents a -7.87% decrease from the last price of 49.93.
The current consensus among 16 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.